{"AEP": {"Ticker": "AEP", "Company": "American Electric Power", "Sector": "Utilities", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$101 to $98"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["BofA Securities"], "Price_Target": 98.0}, "AMP": {"Ticker": "AMP", "Company": "Ameriprise Financial", "Sector": "Financials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$325"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["Keefe Bruyette"], "Price_Target": 325.0}, "T": {"Ticker": "T", "Company": "AT&T", "Sector": "Communication Services", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "MoffettNathanson", "Rating_Change": "Market Perform to Underperform", "Target_Change": "$17"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$20"}, {"Date": "2022-12-08", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$24"}, {"Date": "2022-10-24", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Strong Buy", "Target_Change": "$24"}, {"Date": "2022-10-21", "Rating": "Upgrade", "Organization": "Truist", "Rating_Change": "Hold to Buy", "Target_Change": "$21"}], "Score": 0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Morgan Stanley", "Argus", "MoffettNathanson", "Raymond James", "Truist"], "Price_Target": 21.2}, "BAX": {"Ticker": "BAX", "Company": "Baxter International", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$68 to $55"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$69 to $51"}, {"Date": "2022-12-12", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$64 to $58"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$64"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$62"}], "Score": -0.4, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Deutsche Bank", "Barclays", "Citigroup", "Jefferies", "JP Morgan"], "Price_Target": 58.0}, "CTLT": {"Ticker": "CTLT", "Company": "Catalent", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-11-07", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$125 to $60"}], "Score": -1.33, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Argus", "KeyBanc Capital Markets", "BofA Securities"], "Price_Target": 60.0}, "ENPH": {"Ticker": "ENPH", "Company": "Enphase Energy", "Sector": "Information Technology", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "Northland Capital", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$365"}, {"Date": "2022-12-15", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": "$310 to $365"}, {"Date": "2022-11-15", "Rating": "Initiated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$330"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Northland Capital", "Deutsche Bank", "Susquehanna"], "Price_Target": 353.33}, "LHX": {"Ticker": "LHX", "Company": "L3Harris Technologies", "Sector": "Industrials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Robert W. Baird", "Rating_Change": "Outperform to Neutral", "Target_Change": "$290 to $241"}, {"Date": "2022-12-15", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$263 to $278"}, {"Date": "2022-12-08", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$250"}, {"Date": "2022-11-11", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$285 to $250"}, {"Date": "2022-11-10", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-10-28", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$267"}, {"Date": "2022-10-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2022-09-28", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$238"}], "Score": -0.44, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 9, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Morgan Stanley", "Credit Suisse", "Wells Fargo", "BofA Securities", "Robert W. Baird", "Citigroup", "Wolfe Research", "Argus", "Raymond James"], "Price_Target": 254.0}, "MTD": {"Ticker": "MTD", "Company": "Mettler Toledo", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$1100 to $1350"}, {"Date": "2022-11-08", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Sell to Neutral", "Target_Change": "$1120 to $1355"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan", "Goldman"], "Price_Target": 1352.5}, "MRNA": {"Ticker": "MRNA", "Company": "Moderna", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$170 to $275"}, {"Date": "2022-12-14", "Rating": "Downgrade", "Organization": "Chardan Capital Markets", "Rating_Change": "Buy to Neutral", "Target_Change": "$186 to $191"}, {"Date": "2022-10-21", "Rating": "Upgrade", "Organization": "SVB Leerink", "Rating_Change": "Underperform to Mkt Perform", "Target_Change": "$174 to $101"}], "Score": 0.33, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Chardan Capital Markets", "Jefferies", "SVB Leerink"], "Price_Target": 189.0}, "NRG": {"Ticker": "NRG", "Company": "NRG Energy", "Sector": "Utilities", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Neutral", "Target_Change": ""}, {"Date": "2022-12-09", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$47 to $37"}, {"Date": "2022-12-07", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Neutral to Sell", "Target_Change": "$42 to $30"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Morgan Stanley", "BofA Securities", "UBS"], "Price_Target": 33.5}, "NVDA": {"Ticker": "NVDA", "Company": "Nvidia", "Sector": "Information Technology", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$200 to $230"}, {"Date": "2022-12-15", "Rating": "Initiated", "Organization": "HSBC Securities", "Rating_Change": "Reduce", "Target_Change": "$136"}, {"Date": "2022-11-17", "Rating": "Upgrade", "Organization": "Summit Insights", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-11-16", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$205 to $210"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Credit Suisse", "Summit Insights", "HSBC Securities", "Needham"], "Price_Target": 192.0}, "PNR": {"Ticker": "PNR", "Company": "Pentair", "Sector": "Industrials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2022-12-01", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$48 to $55"}, {"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$42"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Barclays", "JP Morgan", "Stifel"], "Price_Target": 48.5}, "PKI": {"Ticker": "PKI", "Company": "PerkinElmer", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$170"}, {"Date": "2022-12-12", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Neutral to Buy", "Target_Change": "$135 to $170"}, {"Date": "2022-12-06", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$192 to $164"}, {"Date": "2022-11-28", "Rating": "Upgrade", "Organization": "Barclays", "Rating_Change": "Underweight to Equal Weight", "Target_Change": "$130 to $145"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Barclays", "Citigroup", "KeyBanc Capital Markets", "Cowen"], "Price_Target": 162.25}, "RJF": {"Ticker": "RJF", "Company": "Raymond James Financial", "Sector": "Financials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$130 to $120"}, {"Date": "2022-11-22", "Rating": "Initiated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$127"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$120"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$117"}], "Score": -0.5, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["UBS", "Keefe Bruyette", "Citigroup", "Credit Suisse"], "Price_Target": 121.0}, "TSLA": {"Ticker": "TSLA", "Company": "Tesla", "Sector": "Consumer Discretionary", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-11-23", "Rating": "Upgrade", "Organization": "Citigroup", "Rating_Change": "Sell to Neutral", "Target_Change": "$141.33 to $176"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$360 to $288"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Outperform", "Target_Change": "$360 to $300"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "ROTH Capital", "Rating_Change": "Neutral", "Target_Change": "$83.33 to $85"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$340 to $325"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$370 to $330"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$390 to $355"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$244 to $205"}, {"Date": "2022-10-20", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$315 to $325"}, {"Date": "2022-10-14", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$280 to $230"}], "Score": 0.91, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 11, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Deutsche Bank", "BofA Securities", "Wells Fargo", "Cowen", "Citigroup", "Wolfe Research", "ROTH Capital", "Wedbush", "RBC Capital Mkts", "Oppenheimer", "Mizuho"], "Price_Target": 261.9}, "VZ": {"Ticker": "VZ", "Company": "Verizon Communications", "Sector": "Communication Services", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Upgrade", "Organization": "MoffettNathanson", "Rating_Change": "Underperform to Market Perform", "Target_Change": "$41"}, {"Date": "2022-12-15", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$41 to $44"}, {"Date": "2022-10-06", "Rating": "Upgrade", "Organization": "Oppenheimer", "Rating_Change": "Perform to Outperform", "Target_Change": "$50"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Oppenheimer", "Morgan Stanley", "MoffettNathanson"], "Price_Target": 45.0}, "VRTX": {"Ticker": "VRTX", "Company": "Vertex Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$340"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Jefferies"], "Price_Target": 340.0}, "WM": {"Ticker": "WM", "Company": "Waste Management", "Sector": "Industrials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$185 to $171"}, {"Date": "2022-10-25", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Hold to Buy", "Target_Change": "$170 to $191"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Stifel", "Jefferies"], "Price_Target": 181.0}, "XYL": {"Ticker": "XYL", "Company": "Xylem", "Sector": "Industrials", "Updated": "2022-12-19", "Rating": [{"Date": "2022-12-19", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$113 to $115"}, {"Date": "2022-11-16", "Rating": "Upgrade", "Organization": "Atlantic Equities", "Rating_Change": "Neutral to Overweight", "Target_Change": "$110 to $129"}, {"Date": "2022-10-18", "Rating": "Upgrade", "Organization": "Cowen", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$85 to $105"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Stifel", "Atlantic Equities", "Cowen"], "Price_Target": 116.33}}